Stay updated on VGX-3100 & Electroporation for Cervical HSIL Clinical Trial
Sign up to get notified when there's something new on the VGX-3100 & Electroporation for Cervical HSIL Clinical Trial page.

Latest updates to the VGX-3100 & Electroporation for Cervical HSIL Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page footer shows an updated site revision identifier, from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe REVEAL 1 study record is displayed, including its treatment design, eligibility criteria, locations, outcome measures, and study documents.SummaryDifference81%

- Check17 days agoChange DetectedThe footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision label advances from v3.7.1 to v3.7.2. The study record continues to display a 403 error.SummaryDifference1%

- Check45 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1; the study record remains an error page.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error. It replaces the normal study record content with an access-restricted error page.SummaryDifference0.5%

Stay in the know with updates to VGX-3100 & Electroporation for Cervical HSIL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VGX-3100 & Electroporation for Cervical HSIL Clinical Trial page.